Showing results (1-10 of 30) with videos related to
Sort By:
Pageof 3
The Surgical Clinics of North America|October 12, 2025
The Microbiome and Inflammatory Bowel DiseasesSushila R DalalGastroenterology & Hepatology|March 26, 2011
The Role of MicroRNA in Inflammatory Bowel DiseaseSushila R Dalal, John H KwonClinics in Colon and Rectal Surgery|February 27, 2023
The Role of the Microbiome in the Etiology of Inflammatory Bowel DiseasesAriel Halper-Stromberg, Sushila R DalalThe Journal of Clinical Investigation|August 2, 2014
The microbial basis of inflammatory bowel diseasesSushila R Dalal, Eugene B ChangGastroenterology & Hepatology|June 23, 2016
What to Do When Biologic Agents Are Not Working in Inflammatory Bowel Disease PatientsSushila R Dalal, Russell D CohenInflammatory Bowel Diseases|May 29, 2015
Systematic Review: Rectal Therapies for the Treatment of Distal Forms of Ulcerative ColitisRussell D Cohen, Sushila R DalalACG Case Reports Journal|August 3, 2022
Ozanimod Maintenance Therapy After Cyclosporine Induction in Acute Severe Ulcerative ColitisNathaniel A Cohen, Sushila R Dalal, David Choi, et al.Plos One|February 2, 2011
The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancerShien Hu, Tien Sy Dong, Sushila R Dalal, et al.Digestive Diseases and Sciences|June 4, 2026
Combining Guselkumab with Upadacitinib Is Safe and Effective in the Treatment of Medically Complex Inflammatory Bowel DiseaseNavneet Natt, David Choi, Asher Shafrir, et al.Intestinal Research|February 7, 2022
Vedolizumab for perianal fistulizing Crohn's disease: systematic review and meta-analysisFares Ayoub, Matthew Odenwald, Dejan Micic, et al.Pageof 3